Cathie Wood’s Ark Invest sold shares of Palantir Technologies on Tuesday, a trade worth $41.03 million, according to Benzinga. Palantir’s stock declined after its latest earnings report, despite beating analyst expectations, due to elevated investor expectations. The drop follows a sharp 332 annual and 45 year-to-date gain, underscoring ongoing market volatility. Palantir is Ark Invest’s second-largest holding, comprising 8.14 of its portfolio and valued at $421.65 million. Other Ark trades included purchases of Personalis, Guardant Health, Twist Bioscience, Natera, and GitLab.